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Nervous system cancers and acute leukaemias are the most
common malignancies in children (0–14) (Draper et al, 1994;
IARC, 1998; Linet et al, 1999). About 80% of nervous system
cancers are brain tumours, the incidence of which is highest in the
Nordic countries being about 5 per 100 000 per year in Sweden
(Hemminki et al, 1999; Hjalmars et al, 1999). In spite of extensive
studies, the causes of childhood brain cancer remain elusive,
ionizing radiation and genetic predisposition being the only estab-
lished risk factors (Bondy et al, 1991; Draper et al, 1994; Zahm
and Devesa, 1995; Little et al, 1998; Little, 1999; Salminen et al,
1999; Kleihues and Cavenee, 2000). The incidence of brain
tumour, particularly in young children (< 5 years) has increased
moderately in most industrialized countries from the 1960s to the
1990s (Draper et al, 1994; IARC, 1998; Hemminki et al, 1999;
Linet et al, 1999). Brain tumour is a component of certain rare
cancer syndromes such as Li-Fraumeni, neurofibromatosis 1 and
2, von Hippel-Lindau and Gorlin (Li, 1995; Fearon, 1997; Huson,
1998). However, these conditions are likely to explain only a small
proportion of childhood brain tumours; only 2% based on a review
of records (Narod et al, 1991). No increased risk of brain tumour
was observed in parents of childhood brain tumour patients (Olsen
et al, 1995), though among offspring of survivors of childhood
brain tumours the relative risk was 2.0 and almost significant
(Sankila et al, 1998).
Here we analyse the risk of childhood brain tumours of defined
histological types by parental cancer using the nationwide
Swedish Family-Cancer Database (Hemminki et al., 1998;
Hemminki and Vaittinen, 1999; Hemminki and Dong, 2000).
Risks to siblings are also determined. The Database offers unique
possibilities for reliable estimation of familial risks, because the
data on family relationships and cancers were obtained from
registered sources of practically complete coverage (Hemminki
and Vaittinen, 1998a; Hemminki et al, 1998). Here we use the
1999 update of the nationwide Swedish Family-Cancer Database,
now covering 9.6 million individuals in a country of 8.8 million
population.
SUBJECTS AND METHODS
The Swedish Family-Cancer Database includes persons,
(‘offspring’) born in Sweden after 1934 and their biological
parents (Hemminki & Vaittinen, 1998b; Hemminki et al, 1998).
Cancers were retrieved from the nationwide Swedish Cancer
Registry from years 1958 to 1996. A 4-digit diagnostic code
according to the 7th revision of the International Classification of
Diseases (ICD-7) was used. ICD code 1930 was used for brain
tumours. The histological classification of brain tumour was used
to define astrocytoma, pathological anatomic diagnosis (PAD)
codes 471–476, medulloblastoma (436), ependymoma (481–486)
meningioma (461–466) and other subtypes.
There were 3 families with two siblings presenting with child-
hood brain tumours and no families with three or more affected
siblings. In the analysis of parent–offspring risks, the siblings were
treated independently, i.e., a sibship of two affected individuals
contributed two affected parent–offspring pairs. In the analysis of
sibling risks, person-years were calculated for families of one
childhood brain tumour proband. Standardized incidence ratios
(SIRs) were calculated as the ratio of observed (O) to expected (E)
number of cases. The expected numbers were calculated from
5-year-age- and tumour type-standardized rates (Esteve et al,
1994). Confidence intervals (95% CI) were calculated assuming a
Poisson distribution (Esteve et al, 1994).
RESULTS
The Family-Cancer Database included 752 and 2060 cases of
childhood brain cancer, diagnosed before age 5 and before age 15,
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respectively (Table 1). The most common histological types were
astrocytoma, medulloblastoma and ependymoma; less common
types were craniopharyngiomas, pineal tumours and menin-
giomas. Together these accounted for 82% of brain tumours till
age 5 and 80% till age 15.
The SIR for childhood brain tumour was analysed by parental
cancer in Table 2. Paternal and maternal cancer sites were also
analysed separately but because there were no large differences in
SIRs for the common sites, the data in Table 2 were combined for
both parents. SIR by parental nervous system cancer was 2.54 for
offspring diagnosed before age 5 and 1.88 for offspring diagnosed
before age 15. There were no other parental sites that associated
with the risk in offspring. Comparing the numbers of cases from
Tables 1 and 2, we note that 1.3% (10/752, diagnosis < 5 years and
26/2060, diagnosis < 15 years) of childhood brain tumour cases
had a parent with nervous system cancer.
Analysis was carried out by specific subtype of brain tumour 
in offspring (Table 3). The most common type, astrocytoma,
accounted for most of the brain tumours where parents were
affected by nervous system cancer. SIR for astrocytoma was 2.67
when diagnosed < 15 years and 5.14 when diagnosed < 5 years.
Parental salivary gland cancers increased the SIR of medulloblas-
toma to 13.33 but there were only two cases (95% CI, 1.26–38.22).
Ependymoma showed a SIR of 3.70 when parents had colon
cancer. Two ependymoma patients had a mother with endometrial
cancer (SIR 2.17, 95% CI, 0.20–6.23).
We analysed offspring astrocytomas by subtypes of parental
nervous system tumours. SIR for astrocytoma by parental brain
Table 1 Histopathological distribution of childhood brain tumour in the Family-Cancer Database
Age at diagnosis
Histopathological type < 5 < 15
Cases % Cases %
Astrocytoma 333 44.3 1001 48.6
Medulloblastoma 129 17.1 316 15.3
Ependymoma 114 15.1 210 10.2
Craniopharyngioma 20 2.7 77 3.7
Pineal tumours 5 0.7 27 1.3
Meningioma 9 1.2 22 1.1
Others 142 18.9 407 19.8
All 752 100 2060 100
Table 2 SIR for childhood brain tumour by parental cancer
Age at diagnosis
Parental cancer < 5 < 15
O E SIR 95% CI O E SIR 95% CI
No cancer 684 1818
Oral 3 1.74 1.72 0.33 4.23 9 7.3 1.23 0.56 2.17
Salivary glands 2 1.00 2.00 0.19 5.73
Stomach 1 2.09 0.48 0.00 1.88 8 10.3 0.78 0.33 1.41
Colon 4 4.08 0.98 0.26 2.18 20 18.43 1.09 0.66 1.61
Rectum 2 2.48 0.81 0.08 2.31 10 11.18 0.89 0.43 1.53
Liver 2 1.46 1.37 0.13 3.93 4 7.14 0.56 0.15 1.24
Lung 3 4.98 0.60 0.11 1.48 11 21.83 0.50 0.25 0.85
Breast 7 12.7 0.55 0.22 1.04 31 47.35 0.65 0.44 0.91
Cervix 3 2.79 1.08 0.20 2.64 9 10.52 0.86 0.39 1.51
Endometrium 3 1.98 1.52 0.29 3.71 10 9.02 1.11 0.53 1.90
Ovary 4 2.25 1.78 0.46 3.95 7 9.07 0.77 0.31 1.45
Prostate 4 5.46 0.73 0.19 1.63 21 28.67 0.73 0.45 1.08
Kidney 9 10.07 0.89 0.41 1.57
Bladder 3 2.97 1.01 0.19 2.48 7 13.1 0.53 0.21 1.00
Melanoma 5 4.49 1.11 0.35 2.30 17 14.59 1.17 0.68 1.78
Skin 2 1.42 1.41 0.13 4.04 8 6.68 1.20 0.51 2.17
Nervous system 10 3.94 2.54 1.21 4.35 26 13.85 1.88 1.23 2.67
Thyroid gland 2 1.32 1.52 0.14 4.34 5 4.34 1.15 0.36 2.38
Connective tissue 2 0.71 2.82 0.27 8.07 5 2.57 1.95 0.61 4.02
Lymphoma 1 3.37 0.30 0.00 1.16 8 12.41 0.64 0.28 1.17
Leukaemia 2 2.02 0.99 0.09 2.84 6 8.20 0.73 0.26 1.43
Other sites 7 5.61 1.25 0.49 2.34 23 28.26 0.81 0.52 1.18
Bold type: 95% CI does not include 1.00Brain tumours 409
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Table 3 SIR for childhood brain tumour subtypes (diagnosis < 15 years) by parental cancer
Parental cancer Astrocytoma Medulloblastoma Ependymoma
O E SIR 95% CI O E SIR 95% CI O E SIR 95% CI
No cancer 891 284 177
Oral 7 3.55 1.97 0.78 3.70
Salivary glands 2 0.15 13.33 1.26 38.22
Stomach 4 5.01 0.80 0.21 1.77
Colon 3 8.96 0.33 0.06 0.82 4 2.83 1.41 0.37 3.14 7 1.90 3.70 1.47 6.96
Rectum 5 5.44 0.92 0.29 1.90
Liver 3 3.47 0.86 0.16 2.12
Lung 7 10.62 0.66 0.26 1.24 2 3.35 0.6 0.06 1.71
Breast 16 23.03 0.69 0.40 1.08 5 7.26 0.69 0.22 1.42 2 4.85 0.41 0.04 1.18
Cervix 3 5.12 0.59 0.11 1.44
Endometrium 4 4.39 0.91 0.24 2.02 2 0.92 2.17 0.20 6.23
Ovary 4 4.41 0.91 0.24 2.01
Prostate 8 13.95 0.57 0.24 1.04 3 4.4 0.68 0.13 1.67 6 2.94 2.04 0.73 4.00
Kidney 3 4.90 0.61 0.12 1.50 3 1.03 2.91 0.55 7.14
Bladder 4 6.37 0.63 0.16 1.39
Melanoma 8 7.10 1.13 0.48 2.04 5 2.24 2.23 0.70 4.62
Skin 3 3.25 0.92 0.17 2.26 2 1.02 1.96 0.18 5.62 2 0.68 2.94 0.28 8.43
Nervous system 18a 6.74 2.67 1.58 4.05 3 1.42 2.11 0.40 5.18
Thyroid glands 3 2.11 1.42 0.27 3.49
Connective tissue 2 1.25 1.60 0.15 4.59
Lymphoma 2 6.04 0.33 0.03 0.95
Leukaemia 3 3.99 0.75 0.14 1.84
Other sites 7 10.86 0.64 0.26 1.21 11 14.34 0.77 0.38 1.29 12 7.45 1.61 0.83 2.65
Bold type: 95% CI does not include 1.00. aThere were 9 cases with age at diagnosis < 5, SIR 5.14, 95% CI 2.33–9.05.
Table 4 SIR for childhood brain tumour by parental brain cancer
Age at diagnosis of astrocytoma Age at diagnosis of all brain cancer
Parental cancer < 5 < 15 < 5 < 15
O E SIR 95% CI O E SIR 95% CI O E SIR 95% CI O E SIR 95% CI
Astrocytoma 3 0.83 3.61 0.68 8.86 7 3.23 2.17 0.86 4.07 4 1.88 2.13 0.55 4.72 10 6.55 1.53 0.73 2.62
Meningioma 4 0.39 10.26 2.67 22.77 7 1.63 4.29 1.70 8.07 4 0.89 4.49 1.17 9.98 7 3.30 2.12 0.84 3.98
All brain tumours 8 1.56 5.13 2.19 9.30 14 6.11 2.29 1.25 3.65 9 3.53 2.55 1.16 4.49 20 12.38 1.62 0.99 2.40
Bold type: 95% CI does not include 1.00.
Table 5 SIR for cancer in siblings of a childhood brain tumour patient
Sib’s age at diagnosis
Cancer sites < 15 > 15
O E SIR 95% CI O E SIR 95% CI
Colon 2 0.80 2.50 0.24 7.17
Breast 4 3.39 1.18 0.31 2.62
Testis 4 1.25 3.21 0.83 7.13
Melanoma 2 2.25 0.89 0.08 2.54
Nervous system 3a 1.85 1.62 0.31 3.97 7b 1.97 3.55 1.41 6.66
Endocrine glands 3 0.81 3.69 0.70 9.06
Leukaemia 2 1.81 1.11 0.10 3.18 2 0.88 2.27 0.21 6.49
Other sites 3 0.70 4.29 0.81 10.51 3 0.54 5.60 1.06 13.72
Bold type: 95% CI does not include 1.00. a2 sib-pairs had astrocytoma, 1 astrocytoma-ganglioneuroma. b1 sib-pair had astrocytoma, 1 astrocytoma-
medulloblastoma, 1 medulloblastoma, 1 medulloblastoma- ependymoma, 1 neurinoma, 1 ependymoma-pinealoma and 1 astrocytoma-benign tumour (PAD
missing).410 K Hemminki et al
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tumour was 5.13 (< 5 years) and 2.29 (Table 4). When both parents
and offspring had astrocytoma the SIR was 3.61 (< 5 years) and
3.23 (< 15 years). There was a significant association of offspring
astrocytoma with parental meningioma, SIRs being 10.26 and 4.29
when diagnosed before age 5 and 15, respectively. Only one parent
of a brain tumour proband had a brain tumour in childhood. There
were 29 cases of any second cancer in childhood brain tumour
probands, of these seven had a parent with any cancer and two of
these were brain tumour.
Sibling risks were calculated separately for siblings of child-
hood brain tumour probands when the sib was diagnosed before
age 15 or in adult age (15–61 years, Table 5). SIR for brain tumour
in the 3 siblings diagnosed before age 15 was 1.62 but it was 3.55
(95% CI, 1.41–6.66) for brain tumours presenting later. The types
of nervous system cancers in the sib-pairs were heterogeneous as
shown in the footnote; 3/10 pairs were astrocytomas.
DISCUSSION
Childhood brain tumour is represented in many rare cancer
syndromes of high risk (Draper et al, 1996), but hereditary effects
have been ascribed only to some 4% of brain tumours (Bondy
et al, 1991). A study on cancer in parents of childhood cancer
probands found no increase in the risk of nervous system cancer
between the two generations (Olsen et al, 1995); the only parental
site that associated with nervous system cancer in offspring was
rectal tumour in fathers but not in mothers. In the present material
only 1.3% of childhood tumour cases had a parent with nervous
system cancer. SIR for brain tumours in offspring of affected
parents was 2.54 and 1.88, for diagnoses before age 5 or 15,
respectively. We may compare this with the familial risk for
nervous system cancer diagnosed in adult age in the Family-
Cancer Database of 1.8 to 1.9 (Hemminki et al, 1998; Hemminki
and Kyyronen, 1999). The sibling risk for nervous system cancer
of 3.55 included siblings who were diagnosed for nervous system
cancer in ages 15–61 years. Previous studies on siblings and twins
also found moderate risks (Draper et al, 1977; Buckley et al,
1996).
There was an interesting difference in the familial risks by brain
tumour subtypes. Parental nervous system cancers associated only
with offspring astrocytomas, salivary gland cancers associated
with medulloblastomas and colon cancers associated with ependy-
momas. All these findings are novel for population-based studies
on childhood brain tumours. An aggregation of adult astrocytomas
has recently been described from Sweden (Malmer et al, 1999).
Li-Fraumeni syndrome features the occurrence of diverse gliomas
(Sedlacek et al, 1998), and it is possible that some of the astrocy-
toma aggregates were due to this syndrome. The highest risk of
offspring astrocytomas was found in combination with parental
meningioma. This combination could be found in neurofibro-
matosis, particularly of type 2 (Huson, 1998). The association of
brain and colon cancers is known in hereditary non-polyposis
colorectal cancer (HNPCC) and in Turcot’s syndrome but in both
only individual cases of adult ependymoma have been described in
the literature (Vasen et al, 1996; Paraf et al, 1997; Mullins et al,
1998). HNPCC is also associated with a high risk of endometrial
cancer (Aarnio et al, 1999) and in our material there were two
ependymoma patients whose mothers had endometrial cancer (SIR
2.17, 95% CI, 0.20–6.23).
The present data showed distinct patterns of familial risks for
childhood brain tumour including brain astrocytoma-meningioma
between the two generations. Parental colon cancer was associated
with offspring ependymoma, and parental salivary gland cancers
with offspring medulloblastoma. Some of these aggregations may
belong to recognized cancer syndromes but genotyping would be
required for confirmation. Risk of nervous system cancer to
siblings from brain tumour probands was noted when siblings
were followed to adult age.
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